ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) plus olaratumab versus dox plus PBO in patients (pts) with advanced soft tissue sarcomas (STS) Meeting Abstract
| Authors: | Tap, W. D.; Wagner, A. J.; Papai, Z.; Ganjoo, K. N.; Yen, C. C.; Schoffski, P.; Razak, A. R. A.; Broto, J. M.; Spira, A. I.; Kawai, A.; Krarup-Hansen, A.; Le Cesne, A.; Van Tine, B.; Naito, Y.; Park, S. H.; Soldatenkova, V.; Mo, G.; Shahir, A.; Wright, J.; Jones, R. L. |
| Abstract Title: | ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) plus olaratumab versus dox plus PBO in patients (pts) with advanced soft tissue sarcomas (STS) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-06-20 |
| Language: | English |
| ACCESSION: | WOS:000489109800008 |
| DOI: | 10.1200/JCO.2019.37.18_suppl.LBA3 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA3 -- Source: Wos |
